Chronic Obstructive Pulmonary Disease (COPD)

Long-Term Benzodiazepines Do Not Increase Mortality in COPD, PTSD

Long-Term Benzodiazepines Do Not Increase Mortality in COPD, PTSD

For patients with chronic obstructive pulmonary disease and comorbid posttraumatic stress disorder, long-term benzodiazepine use is not associated with mortality, but there is an association for short-term benzodiazepine use.

Collagen Degradation, Formation Elevated in Patients With Exacerbated COPD

Collagen Degradation, Formation Elevated in Patients With Exacerbated COPD

Serologically assessed collagen remodeling plays a key role in the severity of COPD, as determined by airflow limitation and dyspnea, as well as in disease outcomes.

FDA removes Boxed Warning from select asthma, COPD medications

FDA removes Boxed Warning from select asthma, COPD medications

New evidence regarding safety is spurring the US FDA to remove a Boxed Warning from certain inhaled medications used to treat asthma and COPD.

Sign Up for Free e-newsletters